Valuation: Fluicell AB

Market Cap 35.99M 3.57M 3.24M 3M 2.7M 5.09M 337M 5.27M 14.27M 180M 13.41M 13.13M 571M P/E 2024
-1.1x
P/E 2025 -1.65x
Enterprise Value 33.73M 3.35M 3.04M 2.81M 2.53M 4.77M 316M 4.94M 13.37M 169M 12.57M 12.3M 536M EV / Sales 2024
2.04x
EV / Sales 2025 1.91x
Free-Float
78.85%
Yield 2024 *
-
Yield 2025 -
1 day-5.76%
1 week-6.43%
Current month-6.09%
1 month-0.76%
3 months-12.37%
6 months-17.87%
Current year+162.00%
1 week 23.2
Extreme 23.2
29
1 month 23.2
Extreme 23.2
29.4
Current year 7.65
Extreme 7.65
67.2
1 year 7.65
Extreme 7.65
67.2
3 years 7.45
Extreme 7.45
383.6
5 years 7.45
Extreme 7.45
9,625
10 years 7.45
Extreme 7.45
15,330
Manager TitleAgeSince
Chief Executive Officer 42 31/12/2022
Chief Tech/Sci/R&D Officer 46 31/12/2016
Director of Finance/CFO 56 30/06/2023
Director TitleAgeSince
Director/Board Member 54 31/12/2016
Director/Board Member 51 31/12/2016
Director/Board Member 62 31/12/2014
Change 5-day change 1-year change 3-year change Capi.($)
-5.76%-6.43%+101.54%-90.96% 3.57M
-2.69%-0.48%+53.97%+70.99% 66.33B
-0.92%+7.67%+12.64%+92.55% 60.62B
0.00%+0.39%+22.34%+90.83% 55.5B
+0.14%+2.35%+13.86%+106.64% 47.58B
-2.21%-2.47%+20.18%+32.24% 43.69B
-2.30%-10.40%+154.30%+725.54% 37.27B
+2.15%+1.42%+14.58%+54.23% 36.57B
-2.32%-2.24%+76.50%+54.55% 32.22B
+2.62%+5.90%-37.29%+393.72% 26.58B
Average -1.13%-0.60%+43.26%+153.03% 41B
Weighted average by Cap. -0.83%+0.20%+36.63%+155.25%

Financials

2024 2025
Net sales 1.86M 185K 167K 155K 140K 263K 17.41M 272K 737K 9.3M 693K 678K 29.52M 6M 596K 540K 500K 451K 850K 56.21M 879K 2.38M 30.02M 2.24M 2.19M 95.3M
Net income -15.51M -1.54M -1.4M -1.29M -1.16M -2.2M -145M -2.27M -6.15M -77.59M -5.78M -5.66M -246M -8.33M -828K -750K -694K -626K -1.18M -78.02M -1.22M -3.3M -41.68M -3.11M -3.04M -132M
Net Debt -15.92M -1.58M -1.43M -1.33M -1.2M -2.25M -149M -2.33M -6.31M -79.66M -5.93M -5.81M -253M -2.26M -225K -204K -188K -170K -320K -21.18M -331K -897K -11.32M -843K -825K -35.92M
Projected Income Statement - Annual - Fluicell AB
Logo Fluicell AB
Fluicell AB is a Sweden-based company within healthcare industry. It commercializes a product portfolio for processing and studying of individual cells, primarily in the field of drug development. The Company’s products comprise research tools BioPen and Dynaflow Resolve. Tools enable researchers to study, process and measure drug impact on individual cells. Also, the Company develops bioprinting technology Biopixlar Retina in both two-dimensional (2D) and three-dimensional (3D) options. Biopixlar Retina creates complex tissue-like structures with control over positioning of individual cells.
Employees
11
Date Price Change Volume
13/11/26 SEK 26.20 -5.76% 9,447
12/11/26 SEK 27.80 -2.80% 2,474
11/11/26 SEK 28.60 +4.00% 2,216
10/11/26 SEK 27.50 -0.72% 3,039
09/11/26 SEK 27.70 -1.07% 3,910
  1. Stock Market
  2. Stocks
  3. FLUI Stock